Polaris Biology

Polaris Biology was founded in 2016 as a medical technology company focusing on the research and development of single-cell precision diagnostic technologies and their clinical applications. Polaris Biology is committed to using single-cell technology to uncover individual differences and dynamic changes in patients, supporting companion diagnostics and precision treatment in clinical settings. The company currently operates two major technological platforms: mass cytometry analysis technology and circulating tumor cell analysis technology. The circulating tumor cell analysis technology has already been successfully applied in multiple clinical institutions.